Over-diagnosis

In 2004, the FDA added a black-box warning to SSRI antidepressants on the increased risk of suicide among children taking these drugs. A new study suggests that this warning has increased the proportion of children who begin an antidepressant on a low dose, but the majority are still receiving higher than recommended doses.

The authors of a large scale well-conducted systematic review of methylphenidate, also known as Ritalin, conclude that there is a lack of quality evidence for the drug’s effectiveness. Their research also revealed that Ritalin can cause sleep problems and decreased appetite in children.

The latest economic recession led to a spike in diagnoses for mental illnesses, suicide attempts, and suicide, according to report out of the University...

"A classroom program that helps teachers adapt their interactions with students based on individuals' temperaments may lead to more student engagement in kindergarten, more...

“The point, overall, is that given the dizzying array of possible factors at work here, it’s much too pat a story to say that kids are getting more 'fragile' as a result of some cultural bugaboo,” Jesse Singal writes in response to the flurry of recent think pieces decrying the weakened resolve of today's college students.

The abuse of ADHD drugs on college campuses has reached epidemic proportions, according to the authors of a recent review in the journal of Ethical Human Psychology and Psychiatry. ADHD drugs, like Ritalin and Adderall, have become so commonplace on college campuses that students abusing these drugs for studying, weight loss and partying have underestimated their risks. As a result, we have seen exponential increases in emergency room visits, overdoses, and suicides by students taking these drugs.

“In America, medication is becoming almost as much a staple of childhood as Disney and McDonald’s,” writes Sarah Boseley in the Guardian. In this piece photographer Baptiste Lignel follows six boys and girls to examine the long-term effects of these drugs.

A “not otherwise specified” (NOS) diagnosis is often used when an individual may have some symptoms related to a psychiatric diagnosis but does not meet enough criteria to warrant a particular diagnosis. A new study, published online ahead of print in Psychiatric Services, reveals that the proportion of mental health visits resulting in such NOS diagnoses rose to nearly fifty percent, and that these diagnoses do not result in more conservative psychiatric drug prescriptions.

With the American Medical Association (AMA) declaring its opposition to direct-to-consumer (DTC) drug advertising, Martha Rosenberg asks, did DTC increase the number of people who have "diseases"?

In a guest blog for the Scientific American, Peter Kinderman takes on the “harmful myth” that our more distressing emotions can best be understood as symptoms of physical illnesses. “Our present approach to helping vulnerable people in acute emotional distress is severely hampered by old-fashioned, inhumane and fundamentally unscientific ideas about the nature and origins of mental health problems.”

“My vegetable beds have even buoyed me through more acute stressors, such as my medical internship, my daughter’s departure for college, and a loved one’s cancer treatment,” writes Dr. Daphne Miller. Now neuroscientists are attempting to study the antidepressant effects of soil microbes in hopes of unlocking the secrets of a powerful mood enhancer.

The American Academy of Pediatrics came out with new recommendations that suggest doctors screen all of their child patients for hunger. About 16 million children in the US live in food scarcity and poverty that can lead to physical health issues as well as behavioral issues, which can then be misdiagnosed.

Reuters covers a new study in JAMA Psychiatry that suggests that children exposed to physical abuse and emotional abuse suffer from similar psychological and behavioral problems. “Even though doctors and parents often believe physical or sexual abuse is more harmful than emotional mistreatment or neglect, the study found children suffered similar problems regardless of the type of maltreatment endured.”

The Washington Examiner reports that the manufacturer of the antipsychotic Abilify is seeking FDA approval for new digitized pills that would alert doctors if patients fail to take their drugs on schedule.

Dennis Embry, a clinical psychologist and government consultant on mental health, shares a letter he sent to congressman Murphy warning him about how he may have been misled concerning his mental health bill. “I am specifically writing you about erroneous, false information you’ve been given about the National Registry of Evidence Base Programs and Practices. That erroneous information is likely to cause serious problems, which have been withheld from you.”

Professor Wendy Rogers believes that overdiagnosis itself is an epidemic and that the roots of the problem lie in an insufficient naturalistic disease-theory. Overdiagnosis, she adds, “can be harmful for the patient and also cause waste of a lot of resources.”

For the USC Center for Health Journalism, Martha Rosenberg points out the absurdity of allowing industry funded doctors to teach classes to practitioners about psychiatric drugs. "What if the written road test drivers take were sponsored by BP or Shell and had marketing messages interspersed?"

New York Times columnist, Nicholas Kristof, relates the story of Andrew Francesco, a boy who began taking Ritalin at age five and died from complications with Seroquel when he was fifteen. His father, a former pharmaceutical industry executive, reveals the industry’s greed in his memoir “Overmedicated and Undertreated.” Now the industry is pushing for a first-amendment right to market its drugs for off-label uses.

A new study on the depression symptoms of over three-thousand patients challenges the criteria used for diagnosing major depression with the latest Diagnostic and Statistical Manual (DSM-5). Current diagnostic systems are based on an assumption that the symptoms of depression point to a common underlying “illness," but research suggests that this framework may be outdated and oversimplified.

A small study of 30 participants in Germany claims that cannabis can be used to treat “ADHD” because it increases the availability of dopamine. "This then has the same effect but is a different mechanism of action than stimulants like Ritalin and dexedrine amphetamine, which act by binding to the dopamine and interfering with the metabolic breakdown of dopamine." According to the report, 22 of the 30 participants opted to discontinue their prescriptions in favor of medical marijuana.

Robert Neugeboren, who “spent most of his adult life in institutions, often subject to isolation, physical punishment and numbing medication,” was “a celebrity of sorts in the world of the mentally ill: a survivor of the horrors of mistreatment, a case history for those who point to the positive effects of kindness and talk therapy, and, perhaps most of all, the embodiment of the bottomless mystery of the human mind.”

Giving money to people diagnosed with severe mental health issues can significantly improve depression and anxiety. A new study, published in the October issue of the Journal of Community Mental Health, found that giving about $73 US dollars per month for recreational spending can also reduce social isolation and strengthen a sense of self.

In an op-ed for the Guardian, cardiologist Aseem Malhotra writes: “Corporate greed and systematic political failure have brought healthcare to its knees. There are too many misinformed doctors and misinformed patients. It’s time for greater transparency and stronger accountability, so that doctors and nurses can provide the best quality care for the most important person in the consultation room – the patient.”

New research suggests that more frequent in-person contact lessens the risk of depression in older adults. The study, published in this month’s issue of the Journal of the American Geriatric Society, found that in Americans over fifty the more face-to-face contact they had with children, family and friends, the less likely they were to develop depressive symptoms.

The percentage of seniors in the United States prescribed potentially deadly antipsychotic drugs increases with age. A new study reveals that in the face of serious risks of strokes, fractures, kidney injuries, and death, over seventy-five percent of seniors given antipsychotics do not have a diagnosis for a mental disorder.